Rho(d) immune globulin h, sd
Products billed under this code include Winrho SDF.
Payment limit per 100 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Winrho SDF.
Payment limit per 100 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Winrho SDF | Kamada Ltd. | 49591-0300-51 | 150 | $5,309.25 |
| Winrho SDF | Kamada Ltd. | 49591-0330-51 | 15 | $530.925 |
| Winrho SDF | Kamada Ltd. | 49591-0350-51 | 25 | $884.875 |
| Winrho SDF | Kamada Ltd. | 70257-0310-51 | 50 | $1,769.75 |
| Winrho SDF | Kamada Ltd. | 70257-0330-51 | 15 | $530.925 |
| Winrho SDF | Kamada Ltd. | 70257-0350-51 | 25 | $884.875 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $35.395 | −$0.396 | 100 IU | Rho(d) immune globulin h, sd | v1, posted September 17, 2026 |
| 3Q26 | $35.791 | +$1.536 | 100 IU | Rho(d) immune globulin h, sd | v1, posted September 15, 2026 |
| 2Q26 | $34.255 | +$0.345 | 100 IU | Rho(d) immune globulin h, sd | v1, posted September 15, 2026 |
| 1Q26 | $33.91 | +$8.453 | 100 IU | Rho(d) immune globulin h, sd | v1, posted September 15, 2026 |
| 4Q25 | $25.457 | −$5.315 | 100 IU | Rho(d) immune globulin h, sd | v1, posted September 8, 2026 |
| 3Q25 | $30.772 | −$1.735 | 100 IU | Rho(d) immune globulin h, sd | v1, posted March 10, 2026 |
| 2Q25 | $32.507 | −$0.356 | 100 IU | Rho(d) immune globulin h, sd | v1, posted March 10, 2026 |
| 1Q25 | $32.863 | −$1.473 | 100 IU | Rho(d) immune globulin h, sd | v1, posted December 19, 2025 |
| 4Q24 | $34.336 | +$0.613 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 11, 2025 |
| 3Q24 | $33.723 | +$3.082 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 11, 2025 |
| 2Q24 | $30.641 | −$2.323 | 100 IU | Rho(d) immune globulin h, sd | v1, posted March 11, 2025 |
| 1Q24 | $32.964 | −$0.493 | 100 IU | Rho(d) immune globulin h, sd | v1, posted December 19, 2024 |
| 4Q23 | $33.457 | −$0.253 | 100 IU | Rho(d) immune globulin h, sd | v1, posted October 10, 2024 |
| 3Q23 | $33.71 | −$0.505 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 5, 2024 |
| 2Q23 | $34.215 | +$1.292 | 100 IU | Rho(d) immune globulin h, sd | v1, posted February 23, 2024 |
| 1Q23 | $32.923 | +$0.473 | 100 IU | Rho(d) immune globulin h, sd | v1, posted December 6, 2023 |
| 4Q22 | $32.45 | +$0.541 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 22, 2023 |
| 3Q22 | $31.909 | +$1.293 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 9, 2023 |
| 2Q22 | $30.616 | −$0.907 | 100 IU | Rho(d) immune globulin h, sd | v1, posted December 14, 2022 |
| 1Q22 | $31.523 | +$0.107 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 8, 2022 |
| 4Q21 | $31.416 | +$1.386 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 2, 2022 |
| 3Q21 | $30.03 | −$1.544 | 100 IU | Rho(d) immune globulin h, sd | v1, posted June 2, 2022 |
| 2Q21 | $31.574 | +$2.172 | 100 IU | Rho(d) immune globulin h, sd | v1, posted March 1, 2022 |
| 1Q21 | $29.402 | – | 100 IU | Rho(d) immune globulin h, sd | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.